These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 27557507)

  • 1. Sensitizing thermochemotherapy with a PARP1-inhibitor.
    Oei AL; Vriend LE; van Leeuwen CM; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJ; Crezee J; Kanaar R; Kok HP; Krawczyk PM; Franken NA
    Oncotarget; 2017 Mar; 8(10):16303-16312. PubMed ID: 27557507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia.
    Oei AL; van Leeuwen CM; Ahire VR; Rodermond HM; Ten Cate R; Westermann AM; Stalpers LJA; Crezee J; Kok HP; Krawczyk PM; Kanaar R; Franken NAP
    Oncotarget; 2017 Apr; 8(17):28116-28124. PubMed ID: 28427225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked contribution of alternative end-joining to chromosome-translocation-formation by stochastically induced DNA double-strand-breaks in G2-phase human cells.
    Soni A; Siemann M; Pantelias GE; Iliakis G
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():2-8. PubMed ID: 26520366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA double-strand breaks repair inhibitors potentiates the combined effect of VP-16 and CDDP in human colorectal adenocarcinoma (LoVo) cells.
    Kopa P; Macieja A; Pastwa E; Majsterek I; Poplawski T
    Mol Biol Rep; 2021 Jan; 48(1):709-720. PubMed ID: 33389482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatin.
    Robert C; Nagaria PK; Pawar N; Adewuyi A; Gojo I; Meyers DJ; Cole PA; Rassool FV
    Leuk Res; 2016 Jun; 45():14-23. PubMed ID: 27064363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly ADP Ribose Polymerase Inhibitor Olaparib Targeting Microhomology End Joining in Retinoblastoma Protein Defective Cancer: Analysis of the Retinoblastoma Cell-Killing Effects by Olaparib after Inducing Double-Strand Breaks.
    Jiang Y; Yam JC; Chu WK
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly(ADPR)polymerase inhibition and apoptosis induction in cDDP-treated human carcinoma cell lines.
    Gambi N; Tramontano F; Quesada P
    Biochem Pharmacol; 2008 Jun; 75(12):2356-63. PubMed ID: 18468580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiosensitization with an inhibitor of poly(ADP-ribose) glycohydrolase: A comparison with the PARP1/2/3 inhibitor olaparib.
    Gravells P; Neale J; Grant E; Nathubhai A; Smith KM; James DI; Bryant HE
    DNA Repair (Amst); 2018 Jan; 61():25-36. PubMed ID: 29179156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.
    Czyż M; Toma M; Gajos-Michniewicz A; Majchrzak K; Hoser G; Szemraj J; Nieborowska-Skorska M; Cheng P; Gritsyuk D; Levesque M; Dummer R; Sliwinski T; Skorski T
    Oncotarget; 2016 Nov; 7(46):75551-75560. PubMed ID: 27705909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parp1-XRCC1 and the repair of DNA double strand breaks in mouse round spermatids.
    Ahmed EA; de Boer P; Philippens ME; Kal HB; de Rooij DG
    Mutat Res; 2010 Jan; 683(1-2):84-90. PubMed ID: 19887075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The absence of Ku but not defects in classical non-homologous end-joining is required to trigger PARP1-dependent end-joining.
    Mansour WY; Borgmann K; Petersen C; Dikomey E; Dahm-Daphi J
    DNA Repair (Amst); 2013 Dec; 12(12):1134-42. PubMed ID: 24210699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere-Internal Double-Strand Breaks Are Repaired by Homologous Recombination and PARP1/Lig3-Dependent End-Joining.
    Doksani Y; de Lange T
    Cell Rep; 2016 Nov; 17(6):1646-1656. PubMed ID: 27806302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining.
    Bergs JW; Krawczyk PM; Borovski T; ten Cate R; Rodermond HM; Stap J; Medema JP; Haveman J; Essers J; van Bree C; Stalpers LJ; Kanaar R; Aten JA; Franken NA
    DNA Repair (Amst); 2013 Jan; 12(1):38-45. PubMed ID: 23237939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic lethality in DNA repair network: A novel avenue in targeted cancer therapy and combination therapeutics.
    Bhattacharjee S; Nandi S
    IUBMB Life; 2017 Dec; 69(12):929-937. PubMed ID: 29171189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
    Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
    Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MCL-1 dependency of cisplatin-resistant cancer cells.
    Michels J; Obrist F; Vitale I; Lissa D; Garcia P; Behnam-Motlagh P; Kohno K; Wu GS; Brenner C; Castedo M; Kroemer G
    Biochem Pharmacol; 2014 Nov; 92(1):55-61. PubMed ID: 25107702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous Recombination-Mediated DNA Repair and Implications for Clinical Treatment of Repair Defective Cancers.
    Reilly NM; Yard BD; Pittman DL
    Methods Mol Biol; 2019; 1999():3-29. PubMed ID: 31127567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation.
    IJff M; van Bochove GGW; Whitton D; Winiarczyk R; Honhoff C; Rodermond H; Crezee J; Stalpers LJA; Franken NAP; Oei AL
    Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33926008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells.
    Du W; Amarachintha S; Wilson AF; Pang Q
    Sci Rep; 2016 Feb; 6():22167. PubMed ID: 26916217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PARP-mediated repair, homologous recombination, and back-up non-homologous end joining-like repair of single-strand nicks.
    Metzger MJ; Stoddard BL; Monnat RJ
    DNA Repair (Amst); 2013 Jul; 12(7):529-34. PubMed ID: 23684799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.